Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo

DiLillo, David J, Tan, Gene S, Palese, Peter, Ravetch, Jeffrey V·2014·Nature Medicine

DOI 10.1038/nm.3443

Cited by (763)

Items 601–700 of 763

Stereotyped B-cell response that counteracts antigenic variation of influenza viruses
Keisuke Tonouchi, Yu Adachi, Saya Moriyama, Kaori Sano, Koshiro Tabata, Keigo Ide, Haruko Takeyama, Tadaki Suzuki, Yoshimasa Takahashi · 2020 · International Immunology
Influenza Vaccination Results in Differential Hemagglutinin Stalk-Specific Fc-Mediated Functions in Individuals Living With or Without HIV
Boitumelo M. Motsoeneng, Nisha Dhar, Marta Coelho Nunes, Florian Krammer, Shabir Ahmed Madhi, Penny L. Moore, Simone I. Richardson · 2022 · Frontiers in Immunology
Thermostable H1 hemagglutinin stem with M2e epitopes provides broad cross-protection against group1 and 2 influenza A viruses
Jeeva Subbbiah, Judy Oh, Ki‐Hye Kim, Chong Hyun Shin, Bo Ryoung Park, Noopur Bhatnagar, Yu‐Jin Jung, Youri Lee, Bao‐Zhong Wang, Baik Lin Seong et al. · 2022 · Molecular Therapy — Methods & Clinical Development
Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection
Sindhu Vangeti, Sivakumar Periasamy, Peifang Sun, Corey A. Balinsky, Avinash S. Mahajan, Natalia A. Kuzmina, Alessandra Soares Schanoski, Elizabeth S. Cooper, Charmagne G. Beckett, Jan Marayag et al. · 2022 · Microbiology Spectrum
M2e‐specific antibodies protect against influenza PR8 virus in an isotype and route dependent manner
Tingting Sun, Ying-Dan Wang, Peng Zou, Qimin Wang, Jiangyan Liu, Wanli Liu, Jinghe Huang, Fan Wu · 2023 · Journal of Medical Virology
Post-fusion influenza vaccine adjuvanted with SA-2 confers heterologous protection via Th1-polarized, non-neutralizing antibody responses
Ayae Nishiyama, Yu Adachi, Keisuke Tonouchi, Saya Moriyama, Lin Sun, Masamitsu Aoki, Hideki Asanuma, Masayuki Shirakura, Akihisa Fukushima, Takuya Yamamoto et al. · 2023 · Vaccine
A fully human monoclonal antibody possesses antibody‐dependent cellular cytotoxicity (ADCC) activity against the H1 subtype of influenza A virus by targeting a conserved epitope at the HA1 protomer interface
Rongyuan Gao, Zhao Wang, Tirth Uprety, Chithra C. Sreenivasan, Zizhang Sheng, Ben M. Hause, Colin Brunick, Hua Wu, Thomas C Luke, Christoph L Bausch et al. · 2023 · Journal of Medical Virology
Influenza immune imprinting synergizes PEI-HA/CpG nanoparticle vaccine protection against heterosubtypic infection in mice
Chunhong Dong, Yao Ma, Wandi Zhu, Ye Wang, Joo Hee Kim, Lai Wei, Harvinder Singh Gill, Sang‐Moo Kang, Bao‐Zhong Wang · 2023 · Vaccine
An Anti-Influenza Virus Antibody Inhibits Viral Infection by Reducing Nucleus Entry of Influenza Nucleoprotein
Aerin Yoon, Kye Sook Yi, So Young Chang, Sung Hwan Kim, Manki Song, Jung Ah Choi, Melissa Bourgeois, M. Jaber Hossain, Li-Mei Chen, Rubén O. Donis et al. · 2015 · PLoS ONE
Passive Broad-Spectrum Influenza Immunoprophylaxis
Cassandra Berry, W.J. Penhale, Mark Y. Sangster · 2014 · Influenza Research and Treatment
Increased virulence of a PB2/HA mutant of an avian H9N2 influenza strain after three passages in porcine differentiated airway epithelial cells
Wei Lyn Yang, Ruth Lydia Olga Lambertz, Darsaniya Punyadarsaniya, Sarah R. Leist, Jürgen Stech, Klaus Schughart, Georg Herrler, Nai‐Huei Wu, Fandan Meng · 2017 · Veterinary Microbiology
A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
Mark J. Bailey, Felix Broecker, Paul E. Leon, Gene S. Tan · 2018 · Journal of Visualized Experiments
Strain specificities in influence of ageing on germinal centre reaction to inactivated influenza virus antigens in mice: Sex-based differences
Biljana Bufan, Nevena Arsenović-Ranin, Raisa Petrović, Irena P. Zivkovic, Vera Stoiljković, Gordana Leposavić · 2020 · Experimental Gerontology
Hide and seek: interplay between influenza viruses and B cells
Masayuki Kuraoka, Yu Adachi, Yoshimasa Takahashi · 2020 · International Immunology
Influenza Chimeric Protein (3M2e-3HA2-NP) Adjuvanted with PGA/Alum Confers Cross-Protection against Heterologous Influenza A Viruses
Chaewon Kwak, Quyen Thi Nguyen, Jaemoo Kim, Tae-Hwan Kim, Haryoung Poo · 2020 · Journal of Microbiology and Biotechnology
Improved cross-protection and immunity against influenza A virus in mice using a novel mRNA vaccine with optimized design of RNA sequence
Tangqi Wang, Ruiwen Han, Zhanyihao Hao, Xueting Cheng, Jia Li, Chengcheng Zhai, Junjia Guo, Donghong Wang, Yao Deng, Liang Zhang et al. · 2025 · Molecular Therapy — Nucleic Acids
Disulfide-stabilized trimeric hemagglutinin ectodomains provide enhanced heterologous influenza protection
Dejian Liu, Xiuqin Zhong, Yan-Xia Ru, Shi-Long Zhao, Cuicui Liu, Yibo Tang, Xuan Wu, Yi‐Shuai Zhang, Huihui Zhang, Jia-Yue She et al. · 2024 · Emerging Microbes & Infections
Administration of antigenically distinct influenza viral particle combinations as an influenza vaccine strategy
Xinyu Zhu, Zhaochen Luo, Rebecca A. Leonard, Cait E. Hamele, Rachel L. Spreng, Nicholas S. Heaton · 2025 · PLoS Pathogens
Tractable Method for Rapid Quality Assessment of Therapeutic Antibodies in Harvested Cell Culture Fluid based on FcγRIIIa-Immobilized Magnetic Microspheres
Jianan Feng, Linlin Jiang, Yiqing Cao, Chunhui Deng, Yan Li · 2022 · Analytical Chemistry
Safety and Humoral and Cellular Immunogenicity of the BNT162b2 SARS-CoV-2 Vaccine in Liver-Transplanted Adolescents Compared to Healthy Adolescents
Palittiya Sintusek, Supranee Buranapraditkun, Siriporn Khunsri, Varattaya Saengchaisukhonkit, Preeyaporn Vichaiwattana, Donchida Srimuan, Thanunrat Thongmee, Yong Poovorawan · 2022 · Vaccines
Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody
Ahmed Magdy Khalil, Michael S. Piepenbrink, Ian Markham, Madhubanti Basu, Luis Martínez‐Sobrido, James J. Kobie · 2023 · Viruses
From bench to bedside via bytes: Multi-omic immunoprofiling and integration using machine learning and network approaches
Hanxi Xiao, Aaron B.I. Rosen, Prabal Chhibbar, Lenny Moise, Jishnu Das · 2023 · Human Vaccines & Immunotherapeutics
Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins
Daniëla Maria Hinke, Ane Marie Anderson, Kirankumar Katta, Marlene Fyrstenberg Laursen, Demo Yemane Tesfaye, Ina Charlotta Werninghaus, Davide Angeletti, Gunnveig Grødeland, Bjarne Bogen, Ranveig Braathen · 2024 · Nature Communications
Immunogenicity of chimeric hemagglutinins delivered by an orf virus vector platform against swine influenza virus
Gabriela Mansano do Nascimento, Pablo Sebastian Britto de Oliveira, Salman Latif Butt, Diego G. Diel · 2024 · Frontiers in Immunology
Protective Non-neutralizing anti–N-terminal Domain mAb Maintains Fc-mediated Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo Protection against JN.1 Due to Attenuated Virulence
Arman Izadi, Magdalena Godzwon, Anna Söderlund‐Strand, Tobias Schmidt, Susanna Kumlien Georén, Christian Drosten, Mats Ohlin, Pontus Nordenfelt · 2024 · The Journal of Immunology
A MUC16 IgG Binding Activity Selects for a Restricted Subset of IgG Enriched for Certain Simian Immunodeficiency Virus Epitope Specificities
Jeffrey R. Schneider, Xiaoying Shen, Chiara Orlandi, Tinashe E. Nyanhete, Sheetal S. Sawant, Ann M. Carias, Archer D. Smith, Neil L. Kelleher, Ronald S. Veazey, George K. Lewis et al. · 2019 · Journal of Virology
Broadly Neutralizing Antibodies to Highly Antigenically Variable Viruses as Templates for Vaccine Design
Matthias G. Pauthner, Lars Hangartner · 2020 · Current topics in microbiology and immunology
Non-neutralizing monoclonal antibody targeting VP2 EF loop of Coxsackievirus A16 can protect mice from lethal attack via Fc-dependent effector mechanism
Ruixiao Du, Chaoqiang An, Xin Yao, Yiping Wang, Ge Wang, Fan Gao, Lianlian Bian, Yalin Hu, Siyuan Liu, Qiaohui Zhao et al. · 2022 · Emerging Microbes & Infections
Deciphering Fc-mediated Antiviral Antibody Functions in Animal Models
Alan L. Schmaljohn, Chiara Orlandi, George K. Lewis · 2019 · Frontiers in Immunology
FLU-v, a Broad-Spectrum Peptide-Based Influenza Vaccine, Induces NK Cell Activating IgG1 and IgG3 Subclass Antibodies in Humans
Lisbeth Meyer Næss, Hillary A. Vanderven, Diane Bryant Bratlie, Ida Laake, Olga Pleguezuelos, Fredrik Oftung · 2025 · Vaccines
Identification and verification of key molecules in the epileptogenic process of focal cortical dysplasia
Lingman Wang, Jianxiong Gui, Ran Ding, Honghong Song, Bing Tian, Wandi Wang, Jie Liu, Li Jiang · 2024 · Metabolic Brain Disease
A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses
Xin Liu, Thomas Balligand, Camille M. Le Gall, Hidde L. Ploegh · 2025 · Proceedings of the National Academy of Sciences
Analysis of Fc-dependent effector functions of anti-malaria circumsporozoite protein antibodies
Erin Stefanutti, Rashmi Ramani, Bradley M. Whitener, Ha V. Dang, Simon Bélanger, Logeshwaran Somasundaram, Karen Cortina, Anna De Marco, Tommy Tam, Qingqing Chai et al. · 2025 · Microbiology Spectrum
Fc effector functions in RNA viral infections: mechanisms of antiviral immunity and implications for vaccine design
Jiale Zhang, Chuang Li, Yuanyuan Wu, Lili Wang, Jie Yu, Aofan Wang, Wenwen Kong, Mingzhe Ning, J M Chen, Yuxin Chen · 2026 · Frontiers in Immunology
Role of FcγRIII in the nasal cavity of BALB/c mice in the primary amebic meningoencephalitis protection model
Diego Alexander Rojas-Ortega, Saúl Rojas-Hernández, María Elena Sánchez‐Mendoza, Modesto Gómez‐López, Jennifer Viridiana Sánchez-Camacho, Érika Rosales-Cruz, María Maricela Carrasco‐Yépez · 2023 · Parasitology Research
Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses
Sathya N. Thulasi Raman, Adrian Zetner, Anwar M. Hashem, Devina Patel, Jianguo Wu, Caroline Gravel, Jun Gao, Wanyue Zhang, Annabelle Pfeifle, Levi A. Tamming et al. · 2023 · Emerging Microbes & Infections
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens
Hana M. El Sahly, Evan J. Anderson, Lisa A. Jackson, Kathleen Maletic Neuzil, Robert L. Atmar, David I. Bernstein, Wilbur H. Chen, Clarence Buddy Creech, Sharon E. Frey, Paul Goepfert et al. · 2025 · Vaccine
Broad Mucosal and Systemic Immunity in Mice Induced by Intranasal Booster With a Novel Recombinant Adenoviral Based Vaccine Protects Against Divergent Influenza A Virus
Jia Li, Tangqi Wang, Xiaojuan Guo, Yujie Jiang, Liye Jin, Qiaohong Chu, Xuchang Shan, Lingfang Zhang, Ruiwen Han, Chengcheng Zhai et al. · 2025 · Journal of Medical Virology
Combined use of live-attenuated and inactivated influenza vaccines to enhance heterosubtypic protection
Li-Meng Yan, Olive T. W. Li, Chek Meng Poh, Ranawaka A. P. M. Perera, Sophie A. Valkenburg, Malik J. S. Peiris, Leo L. M. Poon · 2018 · Virology
Use of Biolayer Interferometry to Identify Dominant Binding Epitopes of Influenza Hemagglutinin Protein of A(H1N1)pdm09 in the Antibody Response to 2010–2011 Influenza Seasonal Vaccine
Zhu Guo, Xiuhua Lu, Paul J. Carney, Jessie C. Chang, Wen‐Pin Tzeng, Ian A. York, Min Z. Levine, James Stevens · 2023 · Vaccines
Expression of HA1 antigen of H5N1 influenza virus as a potent candidate for vaccine in bacterial system.
A. S. Farsad, Saeid Malekzadeh-Shafaroudi, Nasrin Moshtaghi, Fatemeh Fotouhi, Saeid Zibaee · 2016 · Europe PMC (PubMed Central)
Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014–15
Kelsey R. Florek, James P. Mutschler, Huong Q. McLean, Jennifer P. King, Brendan L. Flannery, Edward A. Belongia, Thomas C. Friedrich · 2019 · Vaccine
Analysis of protective immune responses to seasonal influenza vaccination in HIV-infected individuals
Ying Xia, Fuli Mi, Guoqiang Du, Shenghui Qin · 2020 · Human Vaccines & Immunotherapeutics
Low quality antibody responses in critically ill patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection
Xiuhua Lu, Zhu Guo, Zhu‐Nan Li, Crystal Holiday, Feng Liu, Stacie N. Jefferson, F. Liaini Gross, Wen-Ping Tzeng, Anand Kumar, Ian A. York et al. · 2022 · Scientific Reports
Childhood immunological imprinting of cross-subtype antibodies targeting the hemagglutinin head domain of influenza viruses
Shuk Hang Li, Bo Wang, Gyunghee Jo, Artem I. Mikelov, Reilly K. Atkinson, Valerie Le Sage, Colleen Furey, Jordan T. Ort, Naiqing Ye, Sydney Gang et al. · 2026 · Cell Host & Microbe
Integrative multi-omics analysis in vivo identifies influenza virus host factors
Leah P. Shriver, Benjamin J. Polacco, Manon Eckhardt, Max W. Chang, Carles Martínez‐Romero, Kayla Adkins-Travis, Celina Cahalane, Kelsey M. Haas, David A. Stein, Slim Fourati et al. · 2025 · iScience
Mosaic Inverted Hemagglutinin Extracellular Vesicle Vaccines Elicit Protective Systemic and Mucosal Immunity against Heterosubtypic Influenza Infection
Wandi Zhu, Lai Wei, Chunhong Dong, Joo Kyung Kim, Madeline Bruhn, Yao Ma, Alexander Ferrante, Arini Arsana, Priscilla Omotara, Sang‐Moo Kang et al. · 2026 · ACS Nano
Cross-Reactive Fc-Mediated Antibody Responses to Influenza HA Stem Region in Human Sera Following Seasonal Vaccination
Ayae Nishiyama, Takuto Nogimori, Yuji Masuta, Tomoka Matsuura, Tetsuo Kase, Kyoko Kondo, Satoko Ohfuji, Yu Nakagama, Natsuko Kaku, Sachie Nakagama et al. · 2025 · Vaccines
A constant threat for HIV: Fc‐engineering to enhance broadly neutralizing antibody activity for immunotherapy of the acquired immunodeficiency syndrome
Falk Nimmerjahn · 2015 · European Journal of Immunology
Universal Influenza Vaccine Design: Directing the Antibody Repertoire
Freek Cox, Jarek Juraszek, Esther J. M. Stoop, Jaap Goudsmit · 2016 · Future Virology
Mineralized State of the Avian Influenza Virus in the Environment
Hangyu Zhou, Guangchuan Wang, Xiaoyu Wang, Zhiyong Song, Ruikang Tang · 2017 · Angewandte Chemie
Immunological evaluation of patients with 2019 novel coronavirus pneumonia: CD4+ and CD16+ cells may predict severity and prognosis
Sam Alahyari, Mohsen Rajaeinejad, Hasan Jalaeikhoo, Leila Chegini, Maryam Almasi Aghdam, Ali Asgari, Malihe Nasiri, Alireza Khoshdel, Ali Faridfar · 2022 · PLoS ONE
A Holistic Review of the Preclinical Landscape for Long-Acting Anti-infective Drugs Using HIV as a Paradigm
Megan Neary, Andrew Owen, Adeniyi Olagunju · 2022 · Clinical Infectious Diseases
Headless hemagglutinin-containing influenza viral particles direct immune responses toward more conserved epitopes
Cait E. Hamele, Zhaochen Luo, Rebecca A. Leonard, M. Ariel Spurrier, Kaitlyn N. Burke, Stacy R. Webb, Wes Rountree, Zongli Li, Brook E. Heaton, Nicholas S. Heaton · 2024 · Journal of Virology
Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virus
Giuseppina Di Mario, Elisa Soprana, Francesco Gubinelli, Maddalena Panigada, Marzia Facchini, Concetta Fabiani, Bruno Garulli, Michela Basileo, Antonio Cassone, Antonio G. Siccardi et al. · 2017 · Pathogens and Global Health
Towards a Universal Influenza Virus Vaccine Eliciting Broadly Neutralising Haemagglutinin Antibodies
Cassandra Berry · 2015 · Journal of Vaccines & Vaccination
High-Affinity Neutralizing DNA Aptamers against SARS-CoV-2 Spike Protein Variants
Mohamad Ammar Ayass, Natalya Griko, Victor Pashkov, Trivendra Tripathi, Wanying Cao, Nazanin Javan, Jun Dai, Jin Zhang, Kevin Zhu, Lina Abi-Mosleh · 2023 · COVID
Influenza vaccination and the ‘diversity paradox’
Craig Thompson, Uri Obolski · 2018 · Human Vaccines & Immunotherapeutics
Cross-reactive single-domain antibodies to hemagglutinin stem region protect mice from group 1 influenza A virus infection
Daria V. Voronina, Банделюк Алина Сергеевна, Alina Sh. Dzharullaeva, Olga D. Popova, Vladislav Y. Kan, Ilias B. Esmagambetov, Irina A. Favorskaya, Dmitry V. Shcheblyakov, Boris Savelyevich Naroditskiy, Gintsburg Al · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Heterosubtypic immune pressure accelerates emergence of influenza A virus escape phenotypes in mice
Julie T. S. Chu, Haogao Gu, Wanying Sun, Rebecca L.Y. Fan, John Malcolm Nicholls, Sophie A. Valkenburg, Leo L. M. Poon · 2022 · Virus Research
IgG1 Is the Optimal Subtype for Treating Atherosclerosis by Inducing M2 Macrophage Differentiation, and Is Independent of the FcγRIIA Gene Polymorphism
Rui Duan, Yan Liu, Dongmei Tang, Run Lin, Jinrong Huang, Ming Fei Zhao · 2023 · International Journal of Molecular Sciences
Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A viruses
Wanyue Zhang, Jérémie Prévost, Angela M Sloan, Levi A. Tamming, Annabelle Pfeifle, Caroline Gravel, Sathya N. Thulasi Raman, Gary Van Domselaar, Michael Johnston, Lisheng Wang et al. · 2025 · Antiviral Research
Decoding Protein Glycosylation for Better Vaccine and Antibody Development
Jennifer M. Lo, Chi‐Huey Wong · 2026 · Accounts of Chemical Research
Las vacunas antigripales con adyuvantes estimuladores de la inmunidad innata
Jordi Reina, Cristina Taboada · 2016 · Vacunas
Assessment of Fcγ receptor-dependent binding of influenza hemagglutinin vaccine-induced antibodies in a non-human primate model
Yuji Masuta, Shokichi Takahama, Takuto Nogimori, Saya Moriyama, Yoshimasa Takahashi, Takuya Yamamoto · 2022 · iScience
Switching Heavy Chain Constant Domains Denatures the Paratope 3D Architecture of Influenza Monoclonal Antibodies
Moffat M. Malisheni, Cheng‐Shoong Chong, Tanusya Murali Murali, Kiren Purushotorman, Xinlei Qian, Alfred Laiman, Yee‐Joo Tan, Paul A. MacAry · 2022 · Pathogens
Inactivated and Recombinant Influenza Vaccines
Manish M. Patel, Lisa A. Grohskopf, Suryaprakash R. Sambhara, Jessica A. Belser, Jacqueline M. Katz, Alicia M. Fry · 2023 · Elsevier eBooks
Vaccine-induced neutralizing antibody responses to seasonal influenza virus H1N1 strains are not enhanced during subsequent pandemic H1N1 infection
Petra Mooij, Daniëlla Mortier, Aafke Aartse, Alexandre B. Murad, Ricardo Correia, António Roldão, Paula M. Alves, Zahra C. Fagrouch, Dirk Eggink, N. Stockhofe et al. · 2023 · Frontiers in Immunology
FcγRIIB modulates splenic germinal center response against immune subversion during acute influenza A virus infection
Yu‐Hsuan Wu, Wan-Ting Chang, Chia‐Lang Hsu, Yan-Fong Lu, Jann‐Tay Wang, Shiang‐Jong Tzeng · 2023 · Journal of Microbiology Immunology and Infection
Modulation of T-Cell-Dependent Humoral Immune Response to Influenza Vaccine by Multiple Antioxidant/Immunomodulatory Micronutrient Supplementation
Biljana Bufan, Nevena Arsenović-Ranin, Irena P. Zivkovic, Ivana Ćuruvija, Veljko Blagojević, Luka Dragačević, Ana Kovačević, Jelena Kotur‐Stevuljević, Gordana Leposavić · 2024 · Vaccines
Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes
Philipp Paparoditis, Alexander Fruehwirth, Kajetana Bevc, Jun Siong Low, Josipa Jerak, Laura Terzaghi, Mathilde Foglierini, Blanca Fernandez, David Jarrossay, Davide Corti et al. · 2024 · European Journal of Immunology
Soluble influenza H3 trimer proteins enhance the breadth and potency of antibody response
Cuicui Liu, Yan-Xia Ru, Hui-ru Li, Dejian Liu, Jiaye Liu, Shi-Long Zhao, Xuan Wu, Yousong Peng, Yaowang Li, Lei Deng · 2025 · International Journal of Biological Macromolecules
Fc Functions and Anti-HIV Neutralizing Antibodies: A Perspective
Hillary A. Vanderven, Stephen John Kent · 2025 · Current HIV Research
Applications and insights from continuous dengue virus infection in a stable cell line
Melody Jane Morwitzer, Ying Yi Zheng, Heather Friberg, Jeffrey R. Currier · 2025 · Frontiers in Immunology
FcγRIIIa is a noncanonical costimulatory molecule for CD8 T cells
Kevin Shuolong Kao, Nicole Loren Pihlstrom, Emily G. Niejadlik, Tineke Cantaert, Rafi Ahmed, Jeffrey V. Ravetch, Stylianos Bournazos · 2025 · Proceedings of the National Academy of Sciences
Construction and heterologous expression of a truncated Haemagglutinin (HA) protein from the avian influenza virus H5N1 in Escherichia coli.
Tang Wei, A G Nurul Wahida, S Shaharum · 2014 · PubMed
Selective Capture and Determination of Receptor-Binding Hemagglutinin in Influenza Vaccine Preparations Using a Coupled Receptor-Binding/RP-HPLC Assay
Barry Lorbetskie, Anna‐Maria Cunningham, Michèle Lemieux, Laura Durno, Aaron Farnsworth, Junzhi Wang, Changgui Li, Xuguang Li, Michel Gilbert, Simon Sauvé et al. · 2019 · Analytical Chemistry
SARS-CoV-2 Immunity: Review of Immune Response to Infection and Vaccination
Rahnuma Ahmad · 2021 · Bangladesh Journal of Medical Science
T-Bet Enables Tissue-Restricted B Cell Memory and Influenza Hemagglutinin Stalk-Specific Antibodies
Arpita Myles, James J. Knox, Rebecca L. Rosenthal, Martin S. Naradikian, Joanna Madej, Mariya Kostiv, Scott E. Hensley, Shannon R. Christensen, Jonathan Wilson Yewdell, David H. Canaday et al. · 2018 · SSRN Electronic Journal
Herpes Simplex Viruses Type 1 and Type 2
Antonia Reyes, Mónica A. Farías, Nicolás Corrales, Eduardo I. Tognarelli, Pablo A. González · 2021 · Elsevier eBooks
A class of antibodies that overcome a steric barrier to cross-group neutralization of influenza viruses
Holly C. Simmons, Akiko Watanabe, Thomas H. Oguin, Gregory D. Sempowski, Masayuki Kuraoka, Garnett H. Kelsoe, Kevin R. McCarthy · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Mechanisms Regulating NK Cell Activation During Viral Infection
Catherine A. Forbes, Jérôme D. Coudert · 2015 · Future Virology
Immunological Correlates of Prevention of the Onset of Seasonal H3N2 Influenza
Moe Okuda, Yuko Sakai‐Tagawa, Michiko Koga, Tomohiko Koibuchi, Tadashi Kikuchi, Eisuke Adachi, Lay Ahyoung Lim, Shinya Yamamoto, Hiroshi Yotsuyanagi, Kyota Negishi et al. · 2022 · The Journal of Infectious Diseases
Mucosal immunity elicited by a human-Fcγ receptor-I targeted intranasal vaccine platform enhances resistance against nasopharyngeal colonization of Streptococcus pneumoniae and induces broadly protective immunity against respiratory pathogens
Sudeep Kumar, Karsten R. O. Hazlett, Guangchun Bai · 2025 · Vaccine
More antibodies are not always better: Fc effector functions play a critical role in SARS-CoV-2 infection and protection
Alberto Rubio‐Casillas, Elrashdy M Moustafa Mohamed Redwan, Vladimir Nikolaevich Uversky · 2025 · Progress in molecular biology and translational science
The mechanistic basis for interprotomer deglycosylation of antibodies by corynebacterial IgG-specific endoglycosidases
Diego E. Sastre, Stylianos Bournazos, Maroš Huličiak, Barbara Ann C. Grace, E. Josephine Boder, Jonathan J. Du, Nazneen Ahmeda Sultana, Tala Azzam, Trenton J Brown, Maria W. Flowers et al. · 2025 · Nature Communications
Decreased Fc fucosylation aligns with enhanced RSV-specific antibody functionality in adults compared to young children
Anke J. Lakerveld, Wenjun Wang, Rutger M. Schepp, Jan Nouta, Steinar Gijze, Anne T. Gelderloos, Nynke Y. Rots, Rob S. van Binnendijk, Gestur Vidarsson, Manfred Wuhrer et al. · 2025 · Communications Medicine
A dual-adjuvanted HA stem nanoparticle vaccine elicits a multifunctional antibody response that is associated with protection in newborn monkeys
Kali F. Crofts, Beth C. Holbrook, Courtney L Page, Colby J. Hendrix, David L. Caudell, Rebecca A. Gillespie, Ralph B. D’Agostino, Syed Mohammad Moin, Maya Sangesland, David A. Ornelles et al. · 2026 · Cell Reports Medicine
Prior immunity to seasonal influenza A(H3N2) virus confers varying levels of cross-protection against challenge with clade 2.3.4.4b A(H5N1), A(H7N9), or A(H9N2) virus in a ferret model
Xiangjie Sun, Jessica A. Belser, Zhu‐Nan Li, Feng Liu, Nicole Brock, Joanna A. Pulit-Penaloza, Troy J. Kieran, Claudia Pappas, Hui Zeng, Jessie C. Chang et al. · 2026 · Microbiology Spectrum
Tuberculosis treatment and cytotoxic immune signatures: a longitudinal study
Catherine Sulca, Alessia Piamonte, María Antonieta Quispe-Ricalde, Sandra Delgado, Sandra Patricia Palma Albornoz, Iskra Tuero · 2026 · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Counteracting Influenza Virus Evolution Through the Full Spectrum of Broadly Protective Antibodies
Yu Adachi, Yoshimasa Takahashi · 2026 · Immunological Reviews
CD8+ cytotoxic T lymphocytes in human influenza virus infection
Tao Dong · 2015 · National Science Review
One Against All: A Broadly Influenza Neutralizing Man-made Monoclonal Antibody Passes Phase I
Xavier Saelens · 2016 · EBioMedicine
Noncanonical antibody strategy for broad and potent neutralization of influenza virus
Jordan D. Dimitrov · 2021 · Cellular and Molecular Immunology
Linking Antibodies Against Apolipoprotein A-1 to Metabolic Dysfunction-Associated Steatohepatitis in Mice
Sabrina Pagano, Emmanuel Somm, Catherine Juillard, Nicolas Liaudet, Frédérique Ino, Johan Ferrari, Vincent Braunersreuther, François R. Jornayvaz, Nicolas Vuilleumier · 2024 · International Journal of Molecular Sciences
Omicron Variant Could Be an Antigenic Shift of SARS-CoV-2
Anju Kaushal · 2025 · COVID
Induction of hemagglutinin stalk reactive antibodies by the administration of a live-attenuated influenza virus vaccine in children
Juan Manuel Carreño, Philip S. Meade, Na Fatimata Sogodogo, Kaori Sano, Johnstone Tcheou, Ariel J. Raskin, Gagandeep Singh, Miriam Fried, Madhumathi Loganathan, Benjamin Francis et al. · 2025 · iScience
A live attenuated H5N2 prime- inactivated H5N1 boost vaccination induces influenza virus hemagglutinin stalk specific antibody responses
Alita Kongchanagul, Karnyart Samnuan, Ponthip Wirachwong, Somchaiya Surichan, Pilaipan Puthavathana, Punnee Pitisuttithum, Kobporn Boonnak · 2019 · Vaccine
Toward a Universal Influenza Vaccine: A Retrospective
Yo Han Jang, Baik Lin Seong · 2016 · Future Virology
Commentary on ‘Dissecting the hemagglutinin head and stalk specific IgG antibody response in healthcare workers following pandemic H1N1 vaccination’
Ted M. Ross · 2016 · npj Vaccines